Tag:
osteoarthritis
Latest Headlines
Latest Headlines
Proteins in a drop of fluid mark osteoarthritis risk
Levels of proteins in a single drop of the fluid surrounding the damaged joint can be used to detect whether the patient is developing arthritis, as well as to predict the potential severity of the disease.
Novartis drug discovery repairs arthritic knees in mice
Novartis researchers discovered that a compound called kartogenin promoted the repair of damaged cartilage in arthritic mice.
FDA panel backs effort to lift class hold on anti-NGF pain drugs
Clearing a major roadblock that's keeping Big Pharma from a megablockbuster drug market, a group of FDA experts voted unanimously to allow Pfizer and several other developers to resume testing a...
Biomarker signals joint damage, repair
Researchers have isolated an osteoarthritis biomarker, D-COMP (deaminated cartilage oligomeric matrix protein) that has seemingly conflicting effects: in the circulation, it marks degeneration in the
RNA biomarkers shed light on osteoarthritis
In research presented at the Orthopaedic Research Society 2012 annual meeting, two biomarkers have come to light that might help in the development of disease-modifying treatments for osteoarthritis,
Carticept nails down $10M to fuel Q1 launch of ultrasound drug delivery system
Carticept Medical will launch its new ultrasound-guided, computer-controlled drug delivery system for joint pain medications sometime during its fiscal 2012 first quarter, fueled by a new, $10...
S. Korean biotech snags financing with help from U.S. venture group
South Korea-based CrystalGenomics has reeled in $2.6 million in funding from the Korea Seoul Life Science Fund (KSLSF) to advance its R&D programs in pain and infectious diseases, including an
Researchers ready human trial of osteoarthritis stem cell therapy
UK officials are backing a five-year program to study a new stem cell therapy for osteoarthritis that has the potential to eliminate the need for joint replacement procedures. The new therapy
Anika shares skyrocket on Canadian drug approval
Shares of Anika Therapeutics soared as much as 62 percent this morning after the Bedford, MA-based developer announced that its osteoarthritis therapy won marketing approval in Canada. Monovisc
NicOx shares plunge on Pfizer trial failure
Shares of France's NicOx tumbled 38 percent after Pfizer announced that it would not advance their
